CEL-SCI logo

CEL-SCI

CVM | AMEX
Chart Builder DCF Calculator
$1.66
+$0.38 (+29.69%)
At close: Nov 16, 2026, 4:00 PM ET
$1.67
+$0.01 (+0.60%)
After-hours: Nov 16, 2026, 7:52 PM ET
+29.69%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
24.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #946/1021 (Top 93%)

Key Statistics

Market Data

Market Cap $29.2M
1D Range
1.30 1.75
52W Range
0.97 7.67

Valuation (TTM)

PE -0.64
PB 2.67
EV/EBITDA -1.65

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target $0.00
Loading financial charts...

Profile

CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy candidate, Multikine, is curren...

Sector Healthcare
Industry Biotechnology
Employees 43
IPO Date Dec 8, 1983
Website cel-sci.com
Fiscal Year October - September

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.